Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 9,850.00
-200.00 (-1.99%)
Last updated: Aug 3, 2026, 1:40 PM KST
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 184.1 billion as of August 3, 2026. Its market cap has increased by 1.33% in one year.
Market Cap
184.10B
Enterprise Value
121.06B
Revenue
266.19B
Ranking
n/a
PE Ratio
10.41
Stock Price
9,850.00
ChartMarket Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 184.10B, an increase of 259.43%. That is a compound annual growth rate of 4.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 184.10B | 6.53% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 217.33B |
| Yungjin Pharm. | 212.34B |
| REYON Pharmaceutical | 181.76B |
| Chong Kun Dang Holdings | 181.62B |
| Dong Sung Bio Pharm.Co.,Ltd. | 173.31B |
| JW Lifescience | 172.50B |
| FutureChem Co.,Ltd | 170.86B |
| BNC KOREA | 162.10B |